FDA Inspection
Hubei Biocause Heilen Pharmaceutical Co., Ltd.Hubei Biocause Heilen Pharmaceutical Co., Ltd. – FDA Inspection, Nov 14, 2025
Record Details
This FDA Inspection record concerns Hubei Biocause Heilen Pharmaceutical Co., Ltd., with an inspection on November 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- November 14, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 7685750d-7146-4508-ba7d-1016d7b01a6d
Inspection Facts
- Inspection number
- 1296860
- FDA center
- Human Drugs
Other FDA inspections of Hubei Biocause Heilen Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 4, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hubei Biocause Heilen Pharmaceutical Co., Ltd.
- FDA Inspection 1100057 - 2019-08-16
- FDA Inspection 871443 - 2013-11-22
- FDA Inspection 571882 - 2009-03-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.